Ra Pharmaceuticals Inc
(RARX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 3,000 | 2,500 | 0 | 4,928 | 4,094 |
| Gross Profit | 3,000 | 2,500 | N/A | 4,928 | 4,094 |
| Operating Expenses | 109,979 | 68,888 | 55,029 | 32,952 | 17,450 |
| Operating Income | -106,979 | -66,388 | -55,029 | -28,024 | -13,356 |
| Other Income | 4,291 | 1,426 | 571 | -858 | -606 |
| Pre-tax Income | -102,688 | -64,962 | -54,458 | -28,882 | -13,962 |
| Income Tax | N/A | -19 | -19 | -18 | -19 |
| Net Income Continuous | -102,688 | -64,943 | -54,439 | -28,864 | -13,943 |
| Net Income | $-102,688 | $-64,943 | $-54,439 | $-28,864 | $-13,943 |
| EPS Basic Total Ops | -2.31 | -2.06 | -2.41 | -6.98 | -24.68 |
| EPS Basic Continuous Ops | -2.31 | -2.06 | -2.41 | -6.98 | -28.05 |
| EPS Diluted Total Ops | -2.31 | -2.06 | -2.41 | -6.98 | -24.68 |
| EPS Diluted Continuous Ops | -2.31 | -2.06 | -2.41 | -6.98 | -28.05 |
| EPS Diluted Before Non-Recurring Items | -2.31 | -2.06 | -2.41 | -6.98 | N/A |
| EBITDA(a) | $-105,360 | $-64,791 | $-53,505 | $-26,750 | $-12,459 |